WATERTOWN, Mass.--(BUSINESS WIRE)--Tectonic Therapeutic, Inc. (“Tectonic”) (NASDAQ: TECX), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and ...
Some seven months after sounding the strategic search alarm, Avrobio will merge with Tectonic Therapeutic, with the latter’s GPCR-targeted meds now the combined company's clinical focus. The biotechs’ ...
WATERTOWN, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback